| |
|
|
| |
|
|
| |
| |
hum-molgen: events in
bioscience and medicine |
|
| |
July, 27 2026 |
your calendar for events in genetics, biotechnology
and medicine |
|
| |
|
|
|
|
|
|
| |
advertisement |
|
search meetings |
|
recent postings |
|
|
|
|
| |
=> advertise at hum-molgen
|
|
|
|
| - |
Poor drug solubility continues to be one of the most significant challenges in small molecule drug development, impacting bioavailability, formulation design, clinical performance, timelines and overa: Improve Drug Solubility from Formulation to Scale-Up |
| - |
Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, : Advancing Precision Oncology with Biomarker-driven Strategies and Digital Data Solutions |
| - |
Sleep is fundamental to memory consolidation and neural repair, making it one of the most biologically meaningful signals we can measure in aging and neurodegeneration. Sleep disturbances are often am: Sleep as a Window into Early Stages of Alzheimer's Pathophysiology: Implications for Clinical Development |
| - |
Many CMC challenges that emerge during manufacturing originate much earlier in development. They are decisions made months earlier, in cell line development, process design or formulation, without a c: Strengthen CMC Strategy to Prevent Downstream Delays |
| - |
Pharmaceutical manufacturers already know their affordability dollars are under pressure. What far fewer realize is how much of that pressure comes from a single, quiet source: the way copay claims ar: Detect Pharmacy Copay Misuse Before It Erodes GTN |
| - |
The concept of Real-Time Clinical Trials (RTCT) has recently gained significant attention following the FDA's introduction of the RTCT initiative and the launch of pilot programs to explore its feasib: Challenges and Opportunities in Real-Time Clinical Trials |
| - |
Extracting meaningful multi-omic insights from DNA and RNA sequencing data generated from challenging clinical specimens remains a common obstacle in biomarker-driven research and clinical trials. In : Unlocking High-Quality NGS Data from Challenging Clinical Samples |
| - |
Spatial context is fundamental to understanding tissue organization, health and disease, yet traditional dissociative methods can miss how a cell’s location, neighboring cells and local signaling envi: Accelerate Biomarker Discovery with Custom Multiplex Spatial Proteomic Panels |
| - |
Pipetting and liquid handling sit at the heart of nearly every laboratory result, yet they are often overlooked when it comes to compliance and quality oversight. Small errors in volume delivery can c: Improve Regulatory Compliance for Pipetting and Liquid Handling Workflows |
| - |
Artificial intelligence is rapidly entering the clinical trial ecosystem, and clinical operations and data management leaders are under pressure to understand where it can reduce risk in live studies.: Reduce Live Study Risk With AI in eClinical Workflows |
 Get the latest news as RSS feed
|
|
| |
|
|
|
|
|
|
| |
news alert (free) |
|
write an announcement |
|
other resources |
|
| |
|
|
|
|
|
|
| |
To receive our regular news
alert (free - including summary of recent position postings) please register at our
bulletin board.
|
|
Please use our webform for direct postings after you have been set up your account.
By using this site you reach more than
8.000 news alert subscribers and 150.000 HUM-MOLGEN web users and
several mirror sites (e.g. Calender
of Events) in the US, China, Israel and France.
To further improve "hum-molgen: events in bioscience and
medicine" we have redesigned our database and web submission
form. The updated version enables the set up of accounts. By this
way advertisers are in the position to change postings and to submit
multiple postings more efficient. Please report potential problems
/ suggestions for further improvements to the www administrator Kai Garlipp (kai+www@garlipp.de).
|
|
HGMIS Calendar
of Genetic Meetings and Training
Calendar
LifeSciencesInfo.com
How to
Attend a Meeting by Dave Barry
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|